# Role of Anti-TREK-1 Autoantibodies in SCVF

> **NCT06943365** · — · ENROLLING_BY_INVITATION · sponsor: **Institut universitaire de cardiologie et de pneumologie de Québec, University Laval** · enrollment: 300 (estimated)

## Conditions studied

- Short-coupled Ventricular Fibrillation
- Idiopathic Ventricular Fibrillation

## Interventions

- **OTHER:** Repeat plasma screening for the presence or absence of anti-TREK-1 autoantibodies
- **GENETIC:** DPP6 risk haplotype

## Key facts

- **NCT ID:** NCT06943365
- **Lead sponsor:** Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-05-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06943365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06943365, "Role of Anti-TREK-1 Autoantibodies in SCVF". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06943365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*